位置:首页 > 蛋白库 > B4GT3_HUMAN
B4GT3_HUMAN
ID   B4GT3_HUMAN             Reviewed;         393 AA.
AC   O60512; D3DVG3; O60910; Q9BPZ4; Q9H8T2;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 2.
DT   03-AUG-2022, entry version 190.
DE   RecName: Full=Beta-1,4-galactosyltransferase 3 {ECO:0000305};
DE            Short=Beta-1,4-GalTase 3 {ECO:0000303|PubMed:9405390};
DE            Short=Beta4Gal-T3;
DE            Short=b4Gal-T3 {ECO:0000303|PubMed:9405390};
DE            EC=2.4.1.- {ECO:0000269|PubMed:9405390};
DE   AltName: Full=Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;
DE   AltName: Full=Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:9405390};
DE            EC=2.4.1.38 {ECO:0000269|PubMed:9405390};
DE   AltName: Full=N-acetyllactosamine synthase {ECO:0000303|PubMed:9405390};
DE            EC=2.4.1.90 {ECO:0000269|PubMed:9405390};
DE   AltName: Full=Nal synthase;
DE   AltName: Full=Neolactotriaosylceramide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:9405390};
DE            EC=2.4.1.275 {ECO:0000269|PubMed:9405390};
DE   AltName: Full=UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3;
DE   AltName: Full=UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3;
GN   Name=B4GALT3 {ECO:0000312|HGNC:HGNC:926};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9405390; DOI=10.1074/jbc.272.51.31979;
RA   Almeida R., Amado M., David L., Levery S.B., Holmes E.H., Merkx G.,
RA   van Kessel A.G., Rygaard E., Hassan H., Bennett E., Clausen H.;
RT   "A family of human beta4-galactosyltransferases. Cloning and expression of
RT   two novel UDP-galactose:beta-n-acetylglucosamine beta1, 4-
RT   galactosyltransferases, beta4Gal-T2 and beta4Gal-T3.";
RL   J. Biol. Chem. 272:31979-31991(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9597550; DOI=10.1093/glycob/8.5.517;
RA   Lo N.-W., Shaper J.H., Pevsner J., Shaper N.L.;
RT   "The expanding beta 4-galactosyltransferase gene family: messages from the
RT   databanks.";
RL   Glycobiology 8:517-526(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=11588157; DOI=10.1093/glycob/11.10.813;
RA   Guo S., Sato T., Shirane K., Furukawa K.;
RT   "Galactosylation of N-linked oligosaccharides by human beta-1,4-
RT   galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells.";
RL   Glycobiology 11:813-820(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Ovary;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Eye, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   REVIEW.
RX   PubMed=10580128; DOI=10.1016/s0304-4165(99)00168-3;
RA   Amado M., Almeida R., Schwientek T., Clausen H.;
RT   "Identification and characterization of large galactosyltransferase gene
RT   families: galactosyltransferases for all functions.";
RL   Biochim. Biophys. Acta 1473:35-53(1999).
CC   -!- FUNCTION: Responsible for the synthesis of complex-type N-linked
CC       oligosaccharides in many glycoproteins as well as the carbohydrate
CC       moieties of glycolipids. {ECO:0000269|PubMed:11588157,
CC       ECO:0000269|PubMed:9405390}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acetyl-beta-D-glucosaminyl derivative + UDP-alpha-D-
CC         galactose = a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl
CC         derivative + H(+) + UDP; Xref=Rhea:RHEA:22932, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:61631, ChEBI:CHEBI:66914,
CC         ChEBI:CHEBI:133507; EC=2.4.1.38;
CC         Evidence={ECO:0000269|PubMed:11588157, ECO:0000269|PubMed:9405390};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22933;
CC         Evidence={ECO:0000269|PubMed:11588157, ECO:0000269|PubMed:9405390};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-acetyl-D-glucosamine + UDP-alpha-D-galactose = beta-D-
CC         galactosyl-(1->4)-N-acetyl-D-glucosamine + H(+) + UDP;
CC         Xref=Rhea:RHEA:17745, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:60152, ChEBI:CHEBI:66914, ChEBI:CHEBI:506227;
CC         EC=2.4.1.90; Evidence={ECO:0000269|PubMed:9405390};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17746;
CC         Evidence={ECO:0000269|PubMed:9405390};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-
CC         Cer(d18:1(4E)) + UDP-alpha-D-galactose = a neolactoside
CC         nLc4Cer(d18:1(4E)) + H(+) + UDP; Xref=Rhea:RHEA:31499,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17006, ChEBI:CHEBI:17103,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:66914; EC=2.4.1.275;
CC         Evidence={ECO:0000269|PubMed:9405390};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31500;
CC         Evidence={ECO:0000269|PubMed:9405390};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-glucosylceramide + UDP-alpha-D-galactose = beta-D-
CC         galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide + H(+) + UDP;
CC         Xref=Rhea:RHEA:62552, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:66914, ChEBI:CHEBI:79208, ChEBI:CHEBI:83264;
CC         Evidence={ECO:0000269|PubMed:9405390};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62553;
CC         Evidence={ECO:0000269|PubMed:9405390};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a neolactoside IV(3)-beta-GlcNAc-nLc4Cer + UDP-alpha-D-
CC         galactose = beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-
CC         (1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-
CC         beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide + H(+) +
CC         UDP; Xref=Rhea:RHEA:62548, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:66914, ChEBI:CHEBI:90357, ChEBI:CHEBI:144378;
CC         Evidence={ECO:0000269|PubMed:9405390};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62549;
CC         Evidence={ECO:0000269|PubMed:9405390};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=63 uM for GlcNAc-B-S-pNP {ECO:0000269|PubMed:11588157};
CC         KM=0.084 mM for UDP-galactose {ECO:0000269|PubMed:9405390};
CC         KM=0.58 mM for benzyl-beta-D-GlcNAc {ECO:0000269|PubMed:9405390};
CC         KM=13.1 mM for D-GlcNAc {ECO:0000269|PubMed:9405390};
CC         Vmax=64.35 pmol/min/mg enzyme towards UDP-galactose
CC         {ECO:0000269|PubMed:9405390};
CC         Vmax=66.25 pmol/min/mg enzyme towards for benzyl-beta-D-GlcNAc
CC         {ECO:0000269|PubMed:9405390};
CC         Vmax=60.85 pmol/min/mg enzyme towards D-GlcNAc
CC         {ECO:0000269|PubMed:9405390};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:11588157, ECO:0000269|PubMed:9405390}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-
CC       pass type II membrane protein. Note=Trans cisternae of Golgi stack.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60512-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60512-2; Sequence=VSP_014106, VSP_014107;
CC   -!- TISSUE SPECIFICITY: Found in various tissues. Highest expression in
CC       placenta, prostate, testis, ovary, intestine and muscle, and in fetal
CC       brain. {ECO:0000269|PubMed:9405390}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 7 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=Beta-1,4-
CC       galactosyltransferase 3;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_438";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y12509; CAA73111.1; -; mRNA.
DR   EMBL; AF038661; AAC39734.1; -; mRNA.
DR   EMBL; AB024435; BAA75820.1; -; mRNA.
DR   EMBL; AL590714; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK023311; BAB14520.1; -; mRNA.
DR   EMBL; CH471121; EAW52628.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52629.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52630.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52631.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52632.1; -; Genomic_DNA.
DR   EMBL; BC000276; AAH00276.1; -; mRNA.
DR   EMBL; BC006099; AAH06099.1; -; mRNA.
DR   EMBL; BC009985; AAH09985.1; -; mRNA.
DR   CCDS; CCDS1222.1; -. [O60512-1]
DR   RefSeq; NP_001186802.1; NM_001199873.1. [O60512-1]
DR   RefSeq; NP_001186803.1; NM_001199874.1. [O60512-1]
DR   RefSeq; NP_003770.1; NM_003779.3. [O60512-1]
DR   RefSeq; XP_005245623.1; XM_005245566.1. [O60512-1]
DR   AlphaFoldDB; O60512; -.
DR   SMR; O60512; -.
DR   BioGRID; 114246; 124.
DR   IntAct; O60512; 25.
DR   STRING; 9606.ENSP00000480428; -.
DR   SwissLipids; SLP:000000790; -.
DR   CAZy; GT7; Glycosyltransferase Family 7.
DR   GlyConnect; 1032; 6 N-Linked glycans (2 sites).
DR   GlyGen; O60512; 5 sites, 5 N-linked glycans (2 sites).
DR   iPTMnet; O60512; -.
DR   PhosphoSitePlus; O60512; -.
DR   SwissPalm; O60512; -.
DR   BioMuta; B4GALT3; -.
DR   EPD; O60512; -.
DR   jPOST; O60512; -.
DR   MassIVE; O60512; -.
DR   MaxQB; O60512; -.
DR   PaxDb; O60512; -.
DR   PeptideAtlas; O60512; -.
DR   PRIDE; O60512; -.
DR   ProteomicsDB; 49451; -. [O60512-1]
DR   ProteomicsDB; 49452; -. [O60512-2]
DR   Antibodypedia; 2534; 223 antibodies from 27 providers.
DR   DNASU; 8703; -.
DR   Ensembl; ENST00000319769.10; ENSP00000320965.5; ENSG00000158850.15. [O60512-1]
DR   Ensembl; ENST00000367998.5; ENSP00000356977.1; ENSG00000158850.15. [O60512-1]
DR   Ensembl; ENST00000622395.4; ENSP00000480428.1; ENSG00000158850.15. [O60512-1]
DR   GeneID; 8703; -.
DR   KEGG; hsa:8703; -.
DR   MANE-Select; ENST00000319769.10; ENSP00000320965.5; NM_003779.4; NP_003770.1.
DR   UCSC; uc001fyq.3; human. [O60512-1]
DR   CTD; 8703; -.
DR   DisGeNET; 8703; -.
DR   GeneCards; B4GALT3; -.
DR   HGNC; HGNC:926; B4GALT3.
DR   HPA; ENSG00000158850; Low tissue specificity.
DR   MIM; 604014; gene.
DR   neXtProt; NX_O60512; -.
DR   OpenTargets; ENSG00000158850; -.
DR   PharmGKB; PA25225; -.
DR   VEuPathDB; HostDB:ENSG00000158850; -.
DR   eggNOG; KOG3916; Eukaryota.
DR   GeneTree; ENSGT00940000158549; -.
DR   HOGENOM; CLU_044391_1_2_1; -.
DR   InParanoid; O60512; -.
DR   OMA; CDPGGPR; -.
DR   OrthoDB; 1201618at2759; -.
DR   PhylomeDB; O60512; -.
DR   TreeFam; TF312834; -.
DR   BioCyc; MetaCyc:HS08336-MON; -.
DR   PathwayCommons; O60512; -.
DR   Reactome; R-HSA-2022854; Keratan sulfate biosynthesis.
DR   Reactome; R-HSA-975577; N-Glycan antennae elongation.
DR   SignaLink; O60512; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 8703; 31 hits in 1079 CRISPR screens.
DR   ChiTaRS; B4GALT3; human.
DR   GeneWiki; B4GALT3; -.
DR   GenomeRNAi; 8703; -.
DR   Pharos; O60512; Tbio.
DR   PRO; PR:O60512; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O60512; protein.
DR   Bgee; ENSG00000158850; Expressed in oocyte and 196 other tissues.
DR   ExpressionAtlas; O60512; baseline and differential.
DR   Genevisible; O60512; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0003831; F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008378; F:galactosyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003945; F:N-acetyllactosamine synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0006682; P:galactosylceramide biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0070085; P:glycosylation; IBA:GO_Central.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR003859; Galactosyl_T.
DR   InterPro; IPR027791; Galactosyl_T_C.
DR   InterPro; IPR027995; Galactosyl_T_N.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR19300; PTHR19300; 1.
DR   Pfam; PF02709; Glyco_transf_7C; 1.
DR   Pfam; PF13733; Glyco_transf_7N; 1.
DR   PRINTS; PR02050; B14GALTRFASE.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disulfide bond; Glycoprotein; Glycosyltransferase;
KW   Golgi apparatus; Lipid metabolism; Manganese; Membrane; Metal-binding;
KW   Reference proteome; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..393
FT                   /note="Beta-1,4-galactosyltransferase 3"
FT                   /id="PRO_0000080537"
FT   TOPO_DOM        1..10
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        11..31
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        32..393
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   REGION          339..393
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         130..134
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT                   /evidence="ECO:0000250"
FT   BINDING         169..171
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT                   /evidence="ECO:0000250"
FT   BINDING         196..197
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT                   /evidence="ECO:0000250"
FT   BINDING         197
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         226
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT                   /evidence="ECO:0000250"
FT   BINDING         258
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT                   /evidence="ECO:0000250"
FT   BINDING         260..263
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0000250"
FT   BINDING         291..293
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT                   /evidence="ECO:0000250"
FT   BINDING         291
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         303
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        166
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        337
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        385
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        77..119
FT                   /evidence="ECO:0000250"
FT   DISULFID        190..209
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         116..145
FT                   /note="PAGCEPRSRTAIIVPHRAREHHLRLLLYHL -> PAALPPAPLLAAPAACLW
FT                   HLCHPPGWKWNI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_014106"
FT   VAR_SEQ         146..393
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_014107"
FT   CONFLICT        64
FT                   /note="A -> R (in Ref. 2; AAC39734)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        112
FT                   /note="G -> A (in Ref. 2; AAC39734)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        223
FT                   /note="K -> S (in Ref. 2; AAC39734)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   393 AA;  43928 MW;  CA0BF955F95ED1F4 CRC64;
     MLRRLLERPC TLALLVGSQL AVMMYLSLGG FRSLSALFGR DQGPTFDYSH PRDVYSNLSH
     LPGAPGGPPA PQGLPYCPER SPLLVGPVSV SFSPVPSLAE IVERNPRVEP GGRYRPAGCE
     PRSRTAIIVP HRAREHHLRL LLYHLHPFLQ RQQLAYGIYV IHQAGNGTFN RAKLLNVGVR
     EALRDEEWDC LFLHDVDLLP ENDHNLYVCD PRGPRHVAVA MNKFGYSLPY PQYFGGVSAL
     TPDQYLKMNG FPNEYWGWGG EDDDIATRVR LAGMKISRPP TSVGHYKMVK HRGDKGNEEN
     PHRFDLLVRT QNSWTQDGMN SLTYQLLARE LGPLYTNITA DIGTDPRGPR APSGPRYPPG
     SSQAFRQEML QRRPPARPGP LSTANHTALR GSH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024